Ascensia gets 'seal of approval' for Contour Next
By HME News Staff
Updated Tue September 25, 2018
BASEL, Switzerland - The Contour Next BGMS finished top of the list for accuracy, according to the results of a recently published assessment of 18 blood glucose monitoring systems. The system from Ascensia Diabetes Care was the only one to have 100% of data points within protocol limits for accuracy used by the Diabetes Technology Society in their Blood Glucose Monitoring System Surveillance System. Based on the results of the independent assessment, the Contour Next was one of six systems awarded a “seal of approval” by DTS for meeting stringent standards for accuracy. The full results were published in Diabetes Care in August.
Comments